Zions Bancorporation, N.A. Genmab A/S Transaction History

Zions Bancorporation, N.A.

$1.36 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$25.13 - $30.27 $1,985 - $2,391	-79 Reduced 81.44%	18 $0
Q1 2024 May 14, 2024	BUY	$26.43 - $32.77 $237 - $294	9 Added 10.23%	97 $2,000
Q4 2023 Feb 12, 2024	SELL	$27.94 - $35.44 $1,397 - $1,772	-50 Reduced 36.23%	88 $2,000
Q3 2023 Nov 07, 2023	BUY	$35.27 - $42.24 $70 - $84	2 Added 1.47%	138 $4,000
Q2 2023 Jul 28, 2023	SELL	$37.4 - $42.94 $635 - $729	-17 Reduced 11.11%	136 $5,000
Q1 2023 May 10, 2023	SELL	$34.88 - $43.22 $8,545 - $10,588	-245 Reduced 61.56%	153 $5,000
Q4 2022 Feb 10, 2023	BUY	$33.8 - $47.06 $7,537 - $10,494	223 Added 127.43%	398 $16,000
Q3 2022 Nov 08, 2022	BUY	$31.52 - $373.61 $693 - $8,219	22 Added 14.38%	175 $6,000
Q2 2022 Aug 05, 2022	SELL	$26.83 - $38.57 $51,808 - $74,478	-1,931 Reduced 92.66%	153 $5,000
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $7,737 - $9,920	-250 Reduced 10.71%	2,084 $75,000
Q4 2021 Feb 11, 2022	SELL	$35.87 - $47.12 $13,630 - $17,905	-380 Reduced 14.0%	2,334 $92,000
Q3 2021 Nov 10, 2021	BUY	$41.55 - $48.72 $15,788 - $18,513	380 Added 16.28%	2,714 $119,000
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $624 - $846	19 Added 0.82%	2,334 $95,000
Q1 2021 May 13, 2021	BUY	$30.92 - $44.4 $53,089 - $76,234	1,717 Added 287.12%	2,315 $76,000
Q4 2020 Feb 12, 2021	BUY	$33.66 - $40.76 $807 - $978	24 Added 4.18%	598 $24,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $11,541 - $13,499	349 Added 155.11%	574 $21,000
Q2 2020 Aug 13, 2020	BUY	$20.05 - $33.89 $200 - $338	10 Added 4.65%	225 $8,000
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $1,852 - $2,723	-108 Reduced 33.44%	215 $5,000
Q3 2019 Nov 13, 2019	BUY	$18.0 - $21.38 $5,814 - $6,905	323 New	323 $7,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account